Stevioside acts directly on pancreatic β cells to secrete insulin: Actions independent of cyclic adenosine monophosphate and adenosine triphosphate—sensitivie K+-channel activity
Affiliations
- Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark
- Islet Cell Physiology, Novo Nordisk, Copenhangen, Denmark
Correspondence
- Address reprint requests to P.B. Jeppesen, MSci, Department of Endocrinology and Metabolism, Aarhus University Hospital, Tage-Hansens gade 2, DK-8000 Aarhus C, Denmark.

Affiliations
- Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark
- Islet Cell Physiology, Novo Nordisk, Copenhangen, Denmark
Correspondence
- Address reprint requests to P.B. Jeppesen, MSci, Department of Endocrinology and Metabolism, Aarhus University Hospital, Tage-Hansens gade 2, DK-8000 Aarhus C, Denmark.
Affiliations
- Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark
- Islet Cell Physiology, Novo Nordisk, Copenhangen, Denmark
Affiliations
- Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark
- Islet Cell Physiology, Novo Nordisk, Copenhangen, Denmark
Affiliations
- Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark
- Islet Cell Physiology, Novo Nordisk, Copenhangen, Denmark
Article Info
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.
The natural sweetener stevioside, which is found in the plant Stevia rebaudiana Bertoni, has been used for many years in the treatment of diabetes among Indians in Paraguay and Brazil. However, the mechanism for the blood glucose—lowering effect remains unknown . To elucidate the impact of stevioside and its aglucon steviol on insulin release from normal mouse islets and the β-cell line INS-1 were used. Both stevioside and steviol (1 nmol/L to 1 mmol/L) dose-dependently enhanced insulin secretion from incubated mouse islets in the presence of 16.7 mmol/L glucose (P < .05). The insulinotropic effects of stevioside and steviol were critically dependent on the prevailing glucose concentration, ie, stevioside (1 mmol/L) and steviol (1 μmol/L) only potentiated insulin secretion at or above 8.3 mmol/L glucose (P < .05). Interestingly, the insulinotropic effects of both stevioside and steviol were preserved in the absence of extracellular Ca2+. During perifusion of islets, stevioside (1 mmol/L) and steviol (1 μmol/L) had a long-lasting and apparently reversible insulinotropic effect in the presence of 16.7 mmol/L glucose (P < .05). To determine if stevioside and steviol act directly on β cells, the effects on INS-1 cells were also investigated. Stevioside and steviol both potentiated insulin secretion from INS-1 cells (P < .05). Neither stevioside (1 to 100 μmol/L) nor steviol (10 nmol/L to 10 μmol/L) influenced the plasma membrane K+ adenosine triphosphate (KATP+)-sensitive channel activitiy, nor did they alter cyclic adenosine monophosphate (cAMP) levels in islets. In conclusion, stevioside and steviol stimulate insulin secretion via a direct action on β cells. The results indicate that the compounds may have a potential role as antihyperglycemic agents in the treatment of type 2 diabetes mellitus.
To access this article, please choose from the options below
Purchase access to this article
Claim Access
If you are a current subscriber with Society Membership or an Account Number, claim your access now.
Subscribe to this title
Purchase a subscription to gain access to this and all other articles in this journal.
Institutional Access
Visit ScienceDirect to see if you have access via your institution.
Supported by the Danish Medical Research Council, Aarhus Amtssgehus Forskningsfond, and the Research Foundation of Aarhus University.
Article Tools
Related Articles
Searching for related articles..
